External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort by Lorenz Grossar, Sarah Raevens, Christophe Van Steenkiste, Isabelle Colle, Charlotte De Vloo, Hans Orlent, Jeoffrey Schouten, Marie Gallant, Annelien Van Driessche, Sander Lefere, Lindsey Devisscher, Anja Geerts, Hans Van Vlierberghe, Xavier Verhelst

Get full text

A multicentre interventional study to assess blood-borne viral infections in Belgian prisons by Dana Busschots, Cécile Kremer, Rob Bielen, Özgür M. Koc, Leen Heyens, Christian Brixko, Pierre Laukens, Hans Orlent, Pascal Bilaey, Francis De Smet, Geert Hellemans, Gaetan Muyldermans, Luk Van Baelen, Niel Hens, Hans Van Vlierberghe, Geert Robaeys

Get full text

Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium. by Delphine Degré, Thomas Sersté, Luc Lasser, Jean Delwaide, Peter Starkel, Wim Laleman, Philippe Langlet, Hendrik Reynaert, Stefan Bourgeois, Thomas Vanwolleghem, Sergio Negrin Dastis, Thierry Gustot, Anja Geerts, Christophe Van Steenkiste, Chantal de Galocsy, Antonia Lepida, Hans Orlent, Christophe Moreno

Get full text

Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study by Jean-Charles Nault, Nanthara Sritharan, Gontran Verset, Ivan Borbath, Marie Lequoy, Manon Allaire, Hélène Regnault, Isabelle Colle, Hans Orlent, Isabelle Sinapi, Christophe Moreno, Edouard Larrey, Sabrina Sidali, Clémence Hollande, Giuliana Amaddeo, Stanislas Pol, Pierre Nahon, Nathalie Ganne-Carrié, Vincent Levy, Coralie Bloch-Queyrat, Eric Trepo, Mohammed Bouattour

Get full text